ASCO 2015: Nivolumab Shows Highly Promising Activity in Advanced Liver Cancer in Early-Stage Trial

Findings from a phase I/II study suggest that nivolumab is safe and effective in advanced liver cancer. Based on the results of the phase I part of the study, eight (19%) of the 42 evaluable patients ... Author: EMJ Added: 05/31/2015
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts